Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Radiotherapy: Intermediate-risk endometrial cancer--adjuvant treatment.

Literature DB >> 20877416

Radiotherapy: Intermediate-risk endometrial cancer--adjuvant treatment.

Patricia J Eifel.

Abstract

Entities: Disease

Mesh：

Year: 2010 PMID： 20877416 DOI： 10.1038/nrclinonc.2010.138

Source DB: PubMed Journal: Nat Rev Clin Oncol ISSN： 1759-4774 Impact factor: 66.675

× No keyword cloud information.

8 in total

1. Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus: implications for therapy.

Authors: N Kadar; J H Malfetano; H D Homesley
Journal: Obstet Gynecol Date: 1992-10 Impact factor: 7.661

2. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study.

Authors: W T Creasman; C P Morrow; B N Bundy; H D Homesley; J E Graham; P B Heller
Journal: Cancer Date: 1987-10-15 Impact factor: 6.860

3. Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus. Pathology review and analysis of prognostic variables.

Authors: M Hendrickson; J Ross; P J Eifel; R S Cox; A Martinez; R Kempson
Journal: Gynecol Oncol Date: 1982-06 Impact factor: 5.482

4. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.

Authors: C L Creutzberg; W L van Putten; P C Koper; M L Lybeert; J J Jobsen; C C Wárlám-Rodenhuis; K A De Winter; L C Lutgens; A C van den Bergh; E van de Steen-Banasik; H Beerman; M van Lent
Journal: Lancet Date: 2000-04-22 Impact factor: 79.321

5. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.

Authors: R A Nout; V T H B M Smit; H Putter; I M Jürgenliemk-Schulz; J J Jobsen; L C H W Lutgens; E M van der Steen-Banasik; J W M Mens; A Slot; M C Stenfert Kroese; B N F M van Bunningen; A C Ansink; W L J van Putten; C L Creutzberg
Journal: Lancet Date: 2010-03-06 Impact factor: 79.321

6. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

Authors: C P Morrow; B N Bundy; R J Kurman; W T Creasman; P Heller; H D Homesley; J E Graham
Journal: Gynecol Oncol Date: 1991-01 Impact factor: 5.482

7. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients.

Authors: J Aalders; V Abeler; P Kolstad; M Onsrud
Journal: Obstet Gynecol Date: 1980-10 Impact factor: 7.661

8. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study.

Authors: Henry M Keys; James A Roberts; Virginia L Brunetto; Richard J Zaino; Nick M Spirtos; Jeffrey D Bloss; Andrew Pearlman; Mitchell A Maiman; Jeffrey G Bell
Journal: Gynecol Oncol Date: 2004-03 Impact factor: 5.482